GlassScriptPhysician profile
Gregory Bolton
NPI 1699733782
$2,811.29
in general payments reported to CMS, 2019-2025
21 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $817 · 2021: $183 · 2022: $188 · 2023: $932 · 2024: $92.81 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838 · Travel and Lodging: $418 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.77 |
| Travel and Lodging | $417.90 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $932.02 | 2023 | Da Vinci Surgical System |
| Merz North America, INC. | $578.49 | 2020 | |
| Abbvie INC. | $409.51 | 2019-2021 | |
| Lupin INC. | $154.16 | 2019-2020 | |
| Hologic Sales and Service, LLC | $129.33 | 2022 | |
| Evofem Biosciences, INC. | $103.31 | 2021-2025 | Solosec, Phexx, Phexxi |
| Minerva Surgical, INC | $71.08 | 2024 | |
| Baxter Healthcare | $70.87 | 2025 | Perclot |
| Astellas Pharma US INC | $56.90 | 2024-2025 | Veozah |
| Galderma Laboratories, L.P. | $50.76 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $36.89 | 2019 | |
| Therapeuticsmd, INC. | $31.37 | 2020-2021 | |
| Davol INC. | $28.21 | 2025 | Arista |
| Teleflex LLC | $26.84 | 2025 | Quikclot |
| Boston Scientific Corporation | $21.83 | 2025 | Bulkamid |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $20.34 | 2020 | |
| Millicent US INC | $19.83 | 2020 | |
| Sumitomo Pharma America, INC. | $18.85 | 2025 | Gemtesa |
| Exact Sciences Corporation | $17.70 | 2025 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $17.69 | 2025 | Zurzuvae |
| Allergan, INC. | $15.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bolton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.